ストックスクリーナーアプリを入手
4.09
2.25%
0.09
アフターアワーズ：
4.12
0.03
+0.73%
Exozymes Inc (EXOZ) 最新ニュース
Exozymes (EXOZ) grants VP 45,000 stock options - Stock Titan
EXOZ 424B FilingseXoZymes Inc. SEC 424B - Stock Titan
EXOZ 8-K FilingseXoZymes Inc. SEC 8-K - Stock Titan
12 Health Care Stocks Moving In Wednesday's After-Market Session - benzinga.com
eXoZymes (EXOZ) Stock: Curia Deal Moves NCT Toward Commercial Production - Blockonomi
exozymes partners with Curia for NCT manufacturing scale-up By Investing.com - Investing.com Nigeria
exozymes partners with Curia for NCT manufacturing scale-up - Investing.com
exozymes partners with Curia for NCT manufacturing scale-up By Investing.com - Investing.com India
exozymes partners with Curia for NCT manufacturing scale-up By Investing.com - Investing.com Canada
exozymes partners with Curia for NCT manufacturing scale-up By Investing.com - Investing.com UK
eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT - The Joplin Globe
A 3,000-employee manufacturer will help eXoZymes move a product toward larger-scale production. - Stock Titan
Exozymes CEO Michael Heltzen buys $6,405 in company stock By Investing.com - Investing.com South Africa
Exozymes CEO Michael Heltzen buys $6,405 in company stock By Investing.com - Investing.com UK
Exozymes CEO Michael Heltzen buys $6,405 in company stock By Investing.com - Investing.com India
Exozymes CEO Michael Heltzen buys $6,405 in company stock By Investing.com - Investing.com Canada
Exozymes CEO Michael Heltzen buys $6,405 in company stock By Investing.com - Investing.com Australia
Exozymes CEO Michael Heltzen buys $6,405 in company stock - Investing.com
Exozymes (EXOZ) CEO adds stock with August buys and grant - Stock Titan
eXoZymes Inc. (EXOZ) Edges Lower, Holding Support at $6.13 After 0.77% DipNAAIM Exposure - dars.gov.et
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO - Barchart.com
eXoZymes Provides Fourth Quarter and Full Year 2024 Update - Barchart.com
eXoZymes Inc. (EXOZ) Holds Near $7.17 as Shares Trade Within Established RangePut Dominated - vinanet.vn
Primer: eXoZymes (EXOZ US)Aug 2026 - Smartkarma
Exozymes (EXOZ) CSO adds 32,964 shares from RSU vesting - Stock Titan
eXoZymes (EXOZ): Ends Up by 10.00% at $7.04; Trading Range: the Near-Term Reference Band Stretches From $6.69 to $7.39 in the Available RecordKey Reversal Day - vinanet.vn
eXoZymes Q2FY26 Results: Net loss widens to $2.88M, raises $6M - scanx.trade
eXoZymes Q2 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: eXoZymes posts q2 2026 loss as launch plans advance - Investing.com
Earnings call transcript: eXoZymes posts q2 2026 loss as launch plans advance - Investing.com
EXOZ: NCT program exceeded targets; $6M raised and $2M NIH grant secured for R&D and commercialization - TradingView
eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today - The Batesville Daily Guard
eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today - ACCESS Newswire
eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today - Newswire.com
eXoZymes (EXOZ): Ends Up by 10.00% at $7.04; Trading Range: the Near-Term Reference Band Stretches From $6.69 to $7.39 in the Available RecordBreakout Stock Alerts - dars.gov.et
exoZymes reports 10-fold productivity gain in NCT manufacturing By Investing.com - Investing.com Nigeria
exoZymes reports 10-fold productivity gain in NCT manufacturing By Investing.com - Investing.com India
exoZymes reports 10-fold productivity gain in NCT manufacturing By Investing.com - Investing.com South Africa
exoZymes reports 10-fold productivity gain in NCT manufacturing By Investing.com - Investing.com Canada
eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets - ACCESS Newswire
eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets - The Batesville Daily Guard
EXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets - marketscreener.com
eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets - Newswire.com
Will eXoZymes (NASDAQ:EXOZ) Spend Its Cash Wisely? - webull.com
eXoZymes Inc. (EXOZ) Drops 3% to $5.82, Pressuring Key Support at $5.53Narrow Range Breakout - vinanet.vn
eXoZymes Inc. (EXOZ) Drops 3% to $5.82, Pressuring Key Support at $5.53Hedge Fund Favorites - dars.gov.et
MDB Capital Holdings (MDBH) records $16.1M H1 2026 loss and $33.1M eXoZymes stake - Stock Titan
EXOZYMES INC. 2Q 2026: Revenue $0 Net loss $(5.25M) — 10-Q Summary - TradingView
EXoZymes, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
EXOZ 10-Q FilingseXoZymes Inc. SEC 10-Q - Stock Titan
4.22%
大文字化:
|
ボリューム (24 時間):